Clinical Trials Browser

Completed × Colonic Neoplasms × pembrolizumab × Clear all

Diabetes Mellitus, Insulin-Dependent, 12, Bile Duct Neoplasms, Breast Neoplasms, Carcinoma, Carcinoma, Squamous Cell, Colonic Neoplasms, Head and Neck Neoplasms, Liver Neoplasms, Lung Neoplasms, Lymphoma, Neoplasms, Pancreatic Neoplasms, Sarcoma

NCT05662527 2024-08-13

RESET-C

Phase 2 Completed

85 enrolled

Gastrointestinal

Colonic Neoplasms

NCT02834052 2024-06-07

Pembrolizumab + Poly-ICLC in MRP Colon Cancer

Phase 1/2 Completed

42 enrolled 13 charts

Gastrointestinal

Parkinson Disease 4, Autosomal Dominant Lewy Body, Colonic Neoplasms

NCT03871959 2023-02-17

CATRIPCA

Phase 1 Completed

54 enrolled

Gastrointestinal

Colonic Neoplasms, Rectal Neoplasms

NCT03332498 2022-06-03

Pembrolizumab in Combination With Ibrutinib for Advanced, Refractory Colorectal Cancers

Phase 1/2 Completed

40 enrolled 12 charts

Gastrointestinal

Colonic Diseases, Colonic Neoplasms, Colorectal Neoplasms

Clinical Trials

IT-01

RESET-C

Pembrolizumab + Poly-ICLC in MRP Colon Cancer

CATRIPCA

Pembrolizumab in Combination With Ibrutinib for Advanced, Refractory Colorectal Cancers